Climb Bio Inc Defensive Interval Ratio
Climb Bio Inc defensive interval ratio. Climb Bio Inc (CLYM) has a Defensive Interval Ratio of 8551 days as of June 2026. Defensive assets of $139.02 Million (cash $-, short-term investments $139.02 Million, receivables $-) cover 8551 days of daily cash needs of $16.26K/day. See CLYM working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Climb Bio Inc (2020–2025)
Defensive interval ratio of Climb Bio Inc from 2020 to 2025. This chart shows how Climb Bio Inc's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of June 2026, the ratio stands at 8551 days, meaning defensive assets of $139.02 Million can fund 8551 days of operations without new revenue. Check CLYM financial resilience to evaluate the company's liquid asset resilience ratio.
Climb Bio Inc Defensive Interval Ratio by Year (2020–2025)
Climb Bio Inc defensive interval ratio by year from 2020 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Climb Bio Inc from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of Climb Bio Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 3418 days | $65.39 Million | $19.13K/day | $- | $65.39 Million | ▼ -1380 days |
| 2024 | 4797 days | $64.81 Million | $13.51K/day | $- | $63.69 Million | ▲ +2717 days |
| 2023 | 2081 days | $16.15 Million | $7.76K/day | $- | $13.69 Million | ▼ -3096 days |
| 2022 | 5177 days | $86.47 Million | $16.70K/day | $- | $79.98 Million | ▼ -638 days |
| 2021 | 5815 days | $96.08 Million | $16.52K/day | $- | $89.56 Million | ▲ +5815 days |
| 2020 | 0 days | $0.00 | $8.39K/day | $- | $0.00 | — |